SCYNEXIS, Inc. (SCYX)
NASDAQ: SCYX · Real-Time Price · USD
0.8599
-0.0201 (-2.28%)
At close: Aug 12, 2025, 4:00 PM
0.8599
0.00 (0.00%)
Pre-market: Aug 13, 2025, 8:48 AM EDT
bluebird bio Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for bluebird bio.
Price Target: $ (0.00%)
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for bluebird bio.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Apr 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $15 | Buy | Reiterates | $15 | +1,644.39% | Aug 15, 2023 |
| Guggenheim | Guggenheim | Strong Buy Maintains $8 → $9 | Strong Buy | Maintains | $8 → $9 | +946.63% | Apr 3, 2023 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +1,644.39% | Apr 3, 2023 |
| Guggenheim | Guggenheim | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +830.34% | Mar 1, 2023 |
Financial Forecast
Revenue This Year
19.11M
from 3.75M
Increased by 410.22%
Revenue Next Year
66.67M
from 19.11M
Increased by 248.83%
EPS This Year
-0.27
from -0.44
EPS Next Year
0.59
from -0.27
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 31.8M | 119.9M | 190.5M | ||
| Avg | 19.1M | 66.7M | 120.4M | ||
| Low | 9.0M | 21.0M | 39.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 748.1% | 527.5% | 185.8% | ||
| Avg | 410.2% | 248.8% | 80.6% | ||
| Low | 139.2% | 9.7% | -40.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.04 | 1.58 | 3.06 | ||
| Avg | -0.27 | 0.59 | 1.23 | ||
| Low | -0.48 | -0.26 | -0.07 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 419.5% | ||
| Avg | - | - | 109.8% | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.